Welcome to our dedicated page for Astrana Health news (Ticker: AMEH), a resource for investors and traders seeking the latest updates and insights on Astrana Health stock.
Astrana Health, Inc. (NASDAQ: AMEH) operates a physician-led healthcare model combining technology with value-based care delivery. This news hub provides investors and healthcare professionals with essential updates on the company's financial performance, strategic partnerships, and operational developments.
Access curated press releases and news analysis covering AMEH's value-based care initiatives, network expansions, and technology investments. Our repository includes updates on earnings reports, provider network growth, ESG progress, and regulatory developments affecting healthcare management operations.
Key content focuses on financial disclosures, care model innovations, and market expansion strategies across California, Texas, and other service areas. Stay informed about AMEH's physician empowerment programs, population health management advancements, and partnerships enhancing healthcare accessibility.
Bookmark this page for streamlined access to verified updates about Astrana Health's operational milestones. Check regularly for new developments in healthcare technology integration and value-based care delivery models.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported a 50% revenue increase for Q1 2022, totaling $263.3 million, up from $176.1 million in Q1 2021. Despite a net income decline to $12.1 million from $14.5 million, net income attributable to ApolloMed increased 8% to $14.3 million. The company raised its guidance for total revenue and lower ends for net income and EBITDA due to strong membership growth. Key updates include the acquisition of Jade Health Care Medical Group and the appointment of Chan Basho as Chief Strategy Officer and Interim CFO.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will announce its first-quarter financial results for 2022 on May 5, 2022, after the market closes. A conference call to discuss the results is scheduled for 2 p.m. PT / 5 p.m. ET on the same day. The company operates an integrated healthcare delivery platform, focusing on value-based care. This announcement highlights the ongoing commitment of ApolloMed to providing high-quality healthcare solutions through its technology-powered services.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH), a leader in technology-driven healthcare, announced that Co-CEO Brandon Sim will present at two key investor events. The Jefferies Value-Based Healthcare Summit will take place on March 14, 2022, at 10:05 a.m. PT in Miami Beach, followed by the Barclays Global Healthcare Conference on March 16, 2022, at 11:05 a.m. PT. Management will also hold one-on-one meetings and the presentations will be available via live webcast on the company's website.
Apollo Medical Holdings, Inc. (AMEH) reported strong financial results for Q4 and the full year of 2021. Q4 earnings per share (EPS) increased by 11% to $0.30, while total revenue rose 10% to $195.1 million. For the full year, EPS surged 61% to $1.63, with total revenue growing 13% to $773.9 million. Net income also saw significant improvement, totaling $73.9 million, up 95%. The company announced strategic acquisitions, including Jade Health and Orma Health, to enhance its service offerings. Guidance for 2022 projects revenue between $1.03 billion and $1.08 billion.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will release its financial results for the fourth quarter and year ended December 31, 2021, after the market closes on February 24, 2022. A conference call discussing these results is scheduled for 2 p.m. PT / 5 p.m. ET on the same day. Investors can access the call by dialing in 5 minutes early. An accompanying slide presentation will be available on the Company's website after the earnings release.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) has acquired 100% of Orma Health, Inc. and Provider Growth Solutions LLC, enhancing its technology-driven healthcare offerings. Orma Health's Clinical AI platform supports physician groups in delivering value-based care, currently serving over 4,000 Medicare beneficiaries. ApolloMed aims to integrate Orma Health’s capabilities to expand its services and improve patient care through real-time insights. The acquisition cost includes cash and stock payments, with contingent payments based on operational milestones over the next 18 months.
ApolloMed has joined Society 1, an exclusive membership club supporting Asian American-led enterprises. The club's annual event in Los Angeles celebrated diversity in healthcare featuring guest performer John Lloyd Young. Society 1 promotes visibility and influence for Asian Americans, especially in light of recent xenophobic attacks. ApolloMed, known for its technology-driven healthcare solutions, aims to enhance inclusion and equity in the industry. The Asian American community's buying power has surged, projected to reach $1.3 trillion by 2022.
Apollo Medical Holdings (NASDAQ: AMEH) announced that Brandon Sim, Co-CEO, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 10:30 a.m. PT. Interested parties can access the live webcast on the Company's website. Additionally, management will hold virtual one-on-one meetings during the event. ApolloMed specializes in technology-powered healthcare delivery, aiming to enhance value-based care.
Apollo Medical Holdings (NASDAQ: AMEH) announced its affiliate, AP-AMH 2 Medical Corporation, has agreed to acquire Jade Health Care Medical Group. This acquisition targets enhancing ApolloMed's capabilities in patient care, primarily in Northern California. The deal will add around 13,000 members to ApolloMed's network by Q2 2022. Jade Health, serving the San Francisco Bay Area, is known for its culturally competent care through over 350 providers. ApolloMed plans to integrate Jade Health into its technology platform, aiming to improve operational efficiency and patient outcomes.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) has announced the appointment of Weili Dai and J. Lorraine Estradas to its Board of Directors, effective December 31, 2021. Weili Dai, co-founder of Marvell Technology and current Executive Chairwoman of MeetKai, brings over 25 years of technology experience. Lorraine Estradas, CEO of Arroyo Vista Family Health Center, offers extensive knowledge in community healthcare. The company anticipates that their leadership will enhance ApolloMed's technology platform and support its growth strategy in delivering value-based care.
FAQ
What is the market cap of Astrana Health (AMEH)?
